The pH level within the tumor microenvironment plays a critical role in cancer progression. An acidic environment promotes tumor invasion, metastasis, and resistance to therapy. It also impairs the immune response, making it easier for cancer cells to evade detection and destruction. By targeting the pH, buffer therapy aims to disrupt these processes and improve the effectiveness of existing treatments.
